Analytical Data
-
Gene name
TEP1
- Application
-
Alternative Names
TEP1；TLP1；TP1；Telomerase Protein component 1
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P60484
-
Expression Region
1-403aa
-
AA Sequence
MTAIIKEIVSRNKRRYQEDGFDLDLTYIYPNIIAMGFPAERLEGVYRNNI DDVVRFLDSKHKNHYKIYNLCAERHYDTAKFNCRVAQYPFEDHNPPQLEL IKPFCEDLDQWLSEDDNHVAAIHCKAGKGRTGVMICAYLLHRGKFLKAQE ALDFYGEVRTRDKKGVTIPSQRRYVYYYSYLLKNHLDYRPVALLFHKMMF ETIPMFSGGTCNPQFVVCQLKVKIYSSNSGPTRREDKFMYFEFPQPLPVC GDIKVEFFHKQNKMLKKDKMFHFWVNTFFIPGPEETSEKVENGSLCDQEI DSICSIERADNDKEYLVLTLTKNDLDKANKDKANRYFSPNFKVKLYFTKT VEEPSNPEASSSTSVTPDVSDNEPDHYRYSDTTDSDPENEPFDEDQHTQI TKV
-
Molecular Weight
48 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
TEP1 is a crucial recombinant protein that has garnered significant attention in the fields of molecular biology and biotechnology due to its potential applications in therapeutic development and disease diagnosis. Originally identified as a member of the TEP (Thrombospondin type-1 repeat-containing protein) family, TEP1 plays a pivotal role in various biological processes, including immune response and cell signaling. Its unique structural features, including thrombospondin type-1 repeats, suggest that TEP1 might interact with specific receptors or extracellular matrix components, which could be exploited for targeted drug design. Recent studies have demonstrated that TEP1 exhibits significant antifungal and antimicrobial activities, making it a promising candidate for the development of novel antibiotics in the face of increasing antibiotic resistance. Moreover, the recombinant production of TEP1 through genetic engineering techniques has facilitated in-depth functional analysis and the exploration of its therapeutic potential. The use of cell-free systems and microbial hosts for TEP1 expression has further enhanced the efficiency of its production, paving the way for high-yield applications. As researchers continue to unveil the multifunctional capabilities of TEP1, its role in enhancing immune responses and providing protective effects against various pathogens positions it as a pivotal protein in future drug formulations and immunotherapy strategies. Overall, the research surrounding TEP1 recombinant protein not only contributes to our understanding of its biological functions but also underscores its potential utility in combating infectious diseases and advancing medical science.
